Frontlight ResearchEarly access
Trial site
Johannesburg
- 16running trials
- 3closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Triple-negative breast cancer3 trials
- Type 2 diabetes3 trials
- Heart failure2 trials
- Metastatic breast cancer2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- COPD1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- Mesothelioma1 trial
- Obesity1 trial
- and 2 more
- Phase
- Phase 317 trials
- Phase 22 trials
- Status
- Active, not recruiting8 trials
- Not yet recruiting4 trials
- Recruiting4 trials
- Completed3 trials
- Lead sponsor
- AstraZeneca18 trials
- Arcus Biosciences, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Heart failure2 recruiting
- Chronic kidney disease1 recruiting
- High blood pressure1 recruiting
- Lupus (SLE)1 recruiting
- Obesity1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026